  See all
 |
Articles: Marketing/Media/ROI |
Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
Cell Therapeutics, 04/14/09
Free full text
Medtronic Completes Acquisition of CoreValve Inc
Medtronic, 04/13/09
Free full text
Zila to Transfer to The NASDAQ Capital Market
Zila, 04/10/09
Free full text
Pharma Companies Hit With Warnings for Search Marketing
PharmExec, 04/09/09 New Clinical Trials Insurance Portal Streamlines Insurance Purchasing and Management
Applied Clinical Trials, 04/08/09
Free full text
Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market
Cell Therapeutics, 04/07/09
Free full text
Putting Predictive Market Research to the Test
PharmExec, 04/07/09 Ciba and BASF agree to sell Ciba's CHIMASSORB 119 FL hindered amine light stabilizer business to Sabo S.r.l.
Ciba, 04/06/09
Free full text
Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market
Cell Therapeutics, 04/06/09
Free full text
“Steady course for growth in innovative markets”
BayNews International, 04/03/09
Free full text
Ixiaro vaccine receives Marketing Authorization in Europe for the prevention of Japanese Encephalitis
Novartis, 04/03/09
Free full text
Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
BioPure, 04/02/09
Free full text
Whole Foods Market Issues Nationwide Voluntary Recall of In-Shell Pistachio Nuts Due to Possible Health Risk
FDA Drug Alerts, 04/02/09
Free full text
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Medtronic, 04/01/09
Free full text
GAO: Largest small group health insurers gaining market share
American Hospital Association News, 03/31/09
Free full text
Companies use MDDexec event to launch products
b3c newswire, 03/27/09 Drug Sales See Minimal Climb in 2008
PharmExec, 03/26/09 Merck and Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to VIOXX
Merck & Co., 03/24/09
Free full text
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) patches announced
FDA Drug Alerts, 03/24/09
Free full text
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) patches announced
Shire, 03/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
235 Available Pages
|
|
